Becton Dickinson 

$146.67
749
-$1.08-0.73% Today

Statistics

Day High
150.74
Day Low
146.67
52W High
210.02
52W Low
142.35
Volume
228,293,979
Avg. Volume
-
Mkt Cap
41.76B
P/E Ratio
25.76
Dividend Yield
2.84%
Dividend
4.17

Upcoming

Dividends

2.84%Dividend Yield
Mar 26
$1.05
Dec 25
$1.05
Sep 25
$1.04
Jun 25
$1.04
Mar 25
$1.04
10Y Growth
4.48%
5Y Growth
4.56%
3Y Growth
4.5%
1Y Growth
0.72%

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
2.21
2.79
3.38
3.96
Expected EPS
3.132429
Actual EPS
N/A

Financials

7.68%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
43.68BRevenue
3.36BNet Income

Analyst Ratings

184.69Average Price Target
The highest estimate is 215.00.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
46%
Hold
54%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BDX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap100.91B
Medtronic competes directly with Becton Dickinson in the medical devices sector, particularly in areas like surgical instruments and diabetes care products.
Abbott Laboratories
ABT
Mkt Cap152.25B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products that compete with Becton Dickinson's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap166.59B
Thermo Fisher Scientific competes in the supply of laboratory equipment and consumables, directly challenging Becton Dickinson's life sciences segment.
Danaher
DHR
Mkt Cap121.74B
Danaher Corporation's life sciences and diagnostics divisions offer products that compete with Becton Dickinson's portfolio, especially in diagnostics and research.
Stryker
SYK
Mkt Cap121.33B
Stryker Corporation is a competitor in the medical technology field, particularly in surgical equipment and hospital beds, areas where Becton Dickinson also operates.
Boston Scientific
BSX
Mkt Cap85.88B
Boston Scientific Corporation competes with Becton Dickinson in the medical devices market, especially in areas like cardiovascular and endoscopy products.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson's medical devices division offers products that compete across several of Becton Dickinson's key areas, including surgical instruments and infection prevention.
Zimmer Biomet
ZBH
Mkt Cap16.54B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which overlaps with Becton Dickinson's solutions for surgical and rehabilitation products.
Intuitive Surgical
ISRG
Mkt Cap155.16B
Intuitive Surgical, Inc. competes with Becton Dickinson in the surgical instruments market, particularly with its robotic-assisted surgical systems.

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care
Show more...
CEO
Mr. Thomas E. Polen Jr.
Employees
70000
Country
United States
ISIN
US0758871091

Listings

0 Comments

Share your thoughts

FAQ

What is Becton Dickinson stock price today?
The current price of BDX is $146.67 USD — it has decreased by -0.73% in the past 24 hours. Watch Becton Dickinson stock price performance more closely on the chart.
What is Becton Dickinson stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Becton Dickinson stocks are traded under the ticker BDX.
Is Becton Dickinson stock price growing?
BDX stock has risen by +0.41% compared to the previous week, the month change is a -1.78% fall, over the last year Becton Dickinson has showed a -15.45% decrease.
What is Becton Dickinson market cap?
Today Becton Dickinson has the market capitalization of 41.76B
When is the next Becton Dickinson earnings date?
Becton Dickinson is going to release the next earnings report on July 30, 2026.
What were Becton Dickinson earnings last quarter?
BDX earnings for the last quarter are 2.9 USD per share, whereas the estimation was 2.78 USD resulting in a +4.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Becton Dickinson revenue for the last year?
Becton Dickinson revenue for the last year amounts to 43.68B USD.
What is Becton Dickinson net income for the last year?
BDX net income for the last year is 3.36B USD.
Does Becton Dickinson pay dividends?
Yes, BDX dividends are paid quarterly. The last dividend per share was 1.05 USD. As of today, Dividend Yield (FWD)% is 2.84%.
How many employees does Becton Dickinson have?
As of May 27, 2026, the company has 70,000 employees.
In which sector is Becton Dickinson located?
Becton Dickinson operates in the Health & Wellness sector.
When did Becton Dickinson complete a stock split?
Becton Dickinson has not had any recent stock splits.
Where is Becton Dickinson headquartered?
Becton Dickinson is headquartered in Franklin Lakes, United States.